Halifax, Canada · Founded 2012 · Privately Held (backing)
Developer of a microsphere product designed to improve the treatment of hypervascular tumors. ABK Biomedical is based in Halifax, Canada and was founded in 2012. Its last reported valuation was $73 million in Dec 2022. It has raised $122 million across 4 recorded rounds; the latest was a $2.6 million seed round in Oct 2025.
These 11 firms already write checks for companies like ABK Biomedical. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.